Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[New technologies for vaccine development].

Claude Leclerc¹

¹Unité de Régulation Immunitaire et Vaccinologie, Institut Pasteur, 25, rue du Docteur Roux, 75015 Paris, France et Inserm, U833, Paris, France. cleclerc@pasteur.fr

Medecine Sciences : M/S

|April 17, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

TLR9 activation is required for cytotoxic response elicited by baculovirus capsid display.

Immunology·2022

Same author

IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8<sup>+</sup> T-cell responses.

Oncoimmunology·2020

Same author

The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.

Cancer immunology, immunotherapy : CII·2020

Same author

Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8<sup>+</sup> T Cell Responses.

Cell reports·2019

Same author

Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses.

Journal of medicinal chemistry·2018

Same author

Mitochondrial reactive oxygen species regulate the induction of CD8<sup>+</sup> T cells by plasmacytoid dendritic cells.

Nature communications·2018

New vaccine technologies offer rational design approaches to combat infectious diseases like malaria and AIDS, moving beyond traditional empirical methods for improved efficacy and safety.

Area of Science:

Vaccinology
Immunology
Infectious Diseases

Context:

Traditional vaccine development relies on empirical methods, facing limitations against complex pathogens.
Existing vaccines have eradicated smallpox and reduced polio and measles incidence.
Emerging infectious diseases necessitate advanced immunization strategies.

Purpose:

To highlight the limitations of current vaccine technologies.
To introduce novel vaccine development platforms.
To emphasize the shift towards rational vaccine design.

Summary:

Advances in understanding host-pathogen interactions and immune responses enable new vaccine strategies.
These include recombinant microorganisms, polypeptides, viral vectors, synthetic peptides, polysaccharides, and DNA vaccines.

Related Experiment Videos

This facilitates a rational approach to vaccine design, enhancing efficacy and safety.

Impact:

Enables the development of effective vaccines against challenging diseases like malaria, AIDS, and tuberculosis.
Represents a significant advancement in vaccinology, moving beyond empirical approaches.
Promises increased vaccine efficacy and safety through targeted, rational design.